Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety
出版年份 2020 全文链接
标题
Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety
作者
关键词
-
出版物
JOURNAL OF ASTHMA
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2020-01-30
DOI
10.1080/02770903.2020.1723623
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
- (2018) Merin E. Kuruvilla et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life
- (2018) Carlo Lombardi et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- “I have lost in every facet of my life”: the hidden burden of severe asthma
- (2017) Juliet M. Foster et al. EUROPEAN RESPIRATORY JOURNAL
- Severe asthma and quality of life
- (2017) Elham Hossny et al. World Allergy Organization Journal
- Effects of conventional tobacco smoke and nicotine-free cigarette smoke on airway inflammation, airway remodelling and lung function in a triple allergen model of severe asthma
- (2016) C. Tilp et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
- (2016) Njira Lugogo et al. CLINICAL THERAPEUTICS
- Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
- (2016) M. Caminati et al. BMC Pulmonary Medicine
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
- (2016) Hector G Ortega et al. Lancet Respiratory Medicine
- The prevalence of severe refractory asthma
- (2015) Pieter-Paul W. Hekking et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol
- (2015) Emma S. Chambers et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)
- (2014) F. Schleich et al. RESPIRATORY MEDICINE
- The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
- (2014) S. O'Neill et al. THORAX
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search